KNSA vs WMB · P/E 53, rev $677.6M vs P/E 31, rev $6.08B
Kiniksa Pharmaceuticals Ltd (KNSA) versus Williams Companies Inc (WMB) — a side-by-side from cached financials, not a winner call.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Williams Companies Inc (WMB) is a oil & gas midstream company listed on NYSE.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Latest reported WMB revenue for 2026-06-30 was $6.08B. Net income was $1.69B. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
KNSA currently screens at market cap $3.73B and trailing P/E 53.2. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
Not investment advice. Open the KNSA and WMB stock pages for the full models.
Not investment advice.